Atlas Trials

To Evaluate the Efficacy and Safety of HSK31679 in Chinese Patients With Non-Alcoholic Steatohepatitis (NASH) .

Clinical trial NCT06168383 · COMPLETED

Trial details

NCT number
NCT06168383
Sponsor
Haisco Pharmaceutical Group Co., Ltd.
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Non-Alcoholic Steatohepatitis (NASH)
Start date
2024-01-05
Primary completion
2025-12-12
Enrollment
186

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.